#HIV

A new report suggests that governments and global health donors should explore the potential of private pharmacies as a means to enhance access to care for HIV, tuberculosis, and malaria. This recommendation comes in light of decreasing funding for public health systems globally. The report is titled "Private Pharmacies as a Delivery Channel for HIV, TB, and Malaria Care."

During the Adolescent Health Conference in Dar es Salaam, Dr. Seif Shekalaghe, the Permanent Secretary in the Ministry of Health, urged stakeholders to intensify efforts to combat teen pregnancy, reduce HIV transmission among adolescents, and promote school retention for young people. The conference aims to enhance youth health initiatives across Africa.

The Ministry of Health in Uganda has announced the arrival of an additional 19,200 doses of lenacapavir, a long-acting injectable drug for HIV prevention, due to increasing demand. This shipment is expected next month and will primarily be used for administering second injections to individuals already receiving the treatment.

Health educators and HIV/AIDS focal persons in the Karamoja sub-region are receiving training on the implementation of Lenacapavir, a new injectable drug for HIV prevention introduced by the Ministry of Health. This training, organized by the Uganda AIDS Commission in Moroto District, aims to equip health communication officers and focal persons with the necessary skills for the rollout of this six-month HIV prevention jab.

The Ministry of Health announced that demand for Lenacapavir, a new HIV prevention injection launched in April, is currently exceeding the available supply, particularly among men seeking the twice-yearly treatment. Dr. Herbert Kadama, who coordinates Pre-Exposure Prophylaxis (PrEP) at the Ministry, spoke at a meeting with HIV advocates, researchers, and policymakers about the situation.

The Orange Farm taxi rank clinic has been established to provide health services specifically for men, particularly taxi drivers, in response to concerns about HIV and TB. This initiative resulted from discussions between the Orange Farm United Taxi Association and the City of Johannesburg.

The Ministry of Health reported that the demand for Lenacapavir, an HIV prevention injection introduced in Uganda in April, is surpassing the available supplies. Dr. Herbert Kadama, the ministry’s coordinator for Pre-Exposure Prophylaxis, noted that an increasing number of men are seeking the drug. This announcement was made during a meeting with HIV advocates, researchers, and policymakers.

Keletso Mkhwanazi shares their experience receiving lenacapavir, a new HIV prevention injection. Experts indicate that while certain populations are at higher risk for HIV, the jab is available to anyone who is eligible. This article was originally published by Health-e News.

The rollout of lenacapavir, a treatment for HIV, is being implemented selectively, raising concerns about who benefits from it and who does not. While lenacapavir was expected to significantly impact the epidemic, the limited geographic distribution highlights issues of access and equity, suggesting that the approach may reflect political decisions rather than a comprehensive strategy to end HIV.